Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Moore Complaint (2)

Follow the trail taken from Moore's complaint:

2002- Moore and TPL enter into a Commercialization Agreement (ComAg)

2005 Master Agreement between TPL, PTSC and Moore. There is a new Commercialization Agreement between all three parties

Between 2006-2008 TPL added 3 patent portfolios and began marketing & commingling its efforts on all four portfolios. Focus on the MMP was lost

In March 2007 Moore and TPL agree to Amendment 1 of the ComAg agreement. guidance provded by Roger Cook whose firm had been paid by TPL subject to Leckrone's direction and approval

TPL has been in breach of Amendment 1 since March 2007

Amendment 1 para 2- design development & commercialization of Array processor technology.

Question: Did Moore enter into an amendment 1 to the ComAG agreement with TPL that was part of the Master Agreement, whereby TPL was going to market the Array products possibly on our dime? If so, did PTSC know about this and agree to it?


Oct 04, 2010 05:11PM
3
Oct 04, 2010 07:47PM
Share
New Message
Please login to post a reply